IsomAb secures funds to advance peripheral arterial disease treatment
IsomAb has secured £7.5m in a seed funding round to expedite the development of its lead candidate targeting peripheral arterial disease.
Broadview Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Broadview Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Broadview Ventures Today - Breaking & Trending Today
IsomAb Raises £7.5M in Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
)
IsomAb builds towards £35m Series A after £7.5m seed round is backed by US money
Biotech company IsomAb Ltd, whose registered office is at St John’s Innovation Centre in Cambridge, has excited investors with its antibody technology. The company has closed a £7.5 million financing to accelerate its lead candidate to treat peripheral arterial disease.
Source: businessweekly.co.uk
IsomAb Announces Close of £7.5 Million Financing to Accelerate Lead Candidate for Treatment of Peripheral Arterial Disease
/PRNewswire/ -- IsomAb Ltd, a UK-based biotechnology company, announced today the closing of a £7.5 million (approximately US$9.4 million) Seed financing...
Source: prnewswire.com
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
/PRNewswire/ -- Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ("AF"), the...
Source: prnewswire.com